TMJ Stock Overview
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 2/6 |
| Dividends | 4/6 |
Globe Life Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$74.00 |
| 52 Week High | US$119.00 |
| 52 Week Low | US$44.80 |
| Beta | 0.68 |
| 1 Month Change | -27.45% |
| 3 Month Change | -32.73% |
| 1 Year Change | -22.92% |
| 3 Year Change | -15.91% |
| 5 Year Change | -4.32% |
| Change since IPO | 412.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| TMJ | DE Insurance | DE Market | |
|---|---|---|---|
| 7D | 5.0% | -1.3% | -1.0% |
| 1Y | -22.9% | 23.4% | 2.0% |
Return vs Industry: TMJ underperformed the German Insurance industry which returned 23.7% over the past year.
Return vs Market: TMJ underperformed the German Market which returned 2.5% over the past year.
Price Volatility
| TMJ volatility | |
|---|---|
| TMJ Average Weekly Movement | 18.5% |
| Insurance Industry Average Movement | 2.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: TMJ's share price has been volatile over the past 3 months.
Volatility Over Time: TMJ's weekly volatility has increased from 9% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1900 | 3,636 | Frank Svoboda | www.home.globelifeinsurance.com |
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities.
Globe Life Inc. Fundamentals Summary
| TMJ fundamental statistics | |
|---|---|
| Market cap | €6.93b |
| Earnings (TTM) | €930.17m |
| Revenue (TTM) | €5.15b |
7.3x
P/E Ratio1.3x
P/S RatioIs TMJ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMJ income statement (TTM) | |
|---|---|
| Revenue | US$5.54b |
| Cost of Revenue | US$3.83b |
| Gross Profit | US$1.72b |
| Other Expenses | US$715.74m |
| Earnings | US$1.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.65 |
| Gross Margin | 30.98% |
| Net Profit Margin | 18.07% |
| Debt/Equity Ratio | 50.2% |
How did TMJ perform over the long term?
See historical performance and comparison